{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:22:18Z","timestamp":1782948138132,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology Nursing"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.soncn.2023.151409","type":"journal-article","created":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T07:25:43Z","timestamp":1680333943000},"page":"151409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Delphi Study of Core Patient-Reported Outcomes for Advanced Renal Cell Carcinoma and Advanced Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2630-2106","authenticated-orcid":false,"given":"Celia Diez de los Rios de la","family":"Serna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Drury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy H.","family":"Oldenmenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9508-9989","authenticated-orcid":false,"given":"Grigorios","family":"Kotronoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.soncn.2023.151409_bib0001","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of renal cell carcinoma","volume":"75","author":"Capitanio","year":"2019","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.soncn.2023.151409_bib0002","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.soncn.2023.151409_bib0003","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1200\/OP.21.00419","article-title":"Clinical review on the management of metastatic renal cell carcinoma","volume":"18","author":"Tran","year":"2022","journal-title":"JCO Oncol Pract"},{"issue":"S1","key":"10.1016\/j.soncn.2023.151409_bib0004","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.soncn.2023.151409_bib0005","article-title":"Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis","volume":"16","author":"Ghouri","year":"2017","journal-title":"J Carcinog"},{"issue":"6","key":"10.1016\/j.soncn.2023.151409_bib0006","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3348\/kjr.2019.0808","article-title":"Systematic review of studies assessing the health-related quality of life of hepatocellular carcinoma patients from 2009 to 2018","volume":"21","author":"Kang","year":"2020","journal-title":"Korean J Radiol"},{"issue":"1","key":"10.1016\/j.soncn.2023.151409_bib0007","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11136-017-1704-4","article-title":"Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma","volume":"27","author":"de Groot","year":"2018","journal-title":"Qual Life Res"},{"key":"10.1016\/j.soncn.2023.151409_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2021.102043","article-title":"The role of nursing in the management of patients with renal and hepatic cancers: a systematic literature review","volume":"55","author":"Kelly","year":"2021","journal-title":"Eur J Oncol Nurs"},{"key":"10.1016\/j.soncn.2023.151409_bib0009","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2147\/JHC.S300182","article-title":"Hepatocellular carcinoma: an overview of the changing landscape of treatment options","volume":"8","author":"Koulouris","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"issue":"3","key":"10.1016\/j.soncn.2023.151409_bib0010","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/CCO.0000000000000831","article-title":"The roaring 2020s: a new decade of systemic therapy for renal cell carcinoma","volume":"34","author":"Srivastava","year":"2022","journal-title":"Curr Opin Oncol"},{"issue":"12","key":"10.1016\/j.soncn.2023.151409_bib0011","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.annonc.2021.09.014","article-title":"ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma","volume":"32","author":"Powles","year":"2021","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.soncn.2023.151409_bib0012","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.annonc.2021.02.014","article-title":"Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines","volume":"32","author":"Vogel","year":"2021","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.soncn.2023.151409_bib0013","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/jamaoncol.2016.5202","article-title":"Alternating treatment with pazopanib and everolimus vs continuous pazopanib to delay disease progression in patients with metastatic clear cell renal cell cancer: the ROPETAR randomized clinical trial","volume":"3","author":"Cirkel","year":"2017","journal-title":"JAMA Oncol"},{"issue":"11","key":"10.1016\/j.soncn.2023.151409_bib0014","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1158\/1078-0432.CCR-19-2838","article-title":"Patient-reported outcomes from the phase III randomized IMmotion151 trial: atezolizumab\u202f+\u202fbevacizumab versus sunitinib in treatment-na\u00efve metastatic renal cell carcinoma","volume":"26","author":"Atkins","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.soncn.2023.151409_bib0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.19.01882","article-title":"Results of a multicenter phase II study of atezolizumab and bevacizumab for patients with metastatic renal cell carcinoma with variant histology and\/or sarcomatoid features","volume":"38","author":"McGregor","year":"2020","journal-title":"J Clin Oncol"},{"issue":"Jan","key":"10.1016\/j.soncn.2023.151409_bib0016","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fonc.2019.00011","article-title":"Sources of frustration among patients diagnosed with renal cell carcinoma","volume":"9","author":"Bergerot","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.soncn.2023.151409_bib0017","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.2147\/PPA.S236122","article-title":"Core patient-reported outcomes (PROs) and PRO measures (PROMs) for polypharmacy medicines reviews: a sequential mixed-methods study","volume":"13","author":"Kotronoulas","year":"2019","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"10.1016\/j.soncn.2023.151409_bib0018","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s12325-021-02007-y","article-title":"Reviewing treatment options for advanced renal cell carcinoma: is there still a place for tyrosine kinase inhibitor (TKI) monotherapy?","volume":"39","author":"Fontes-Sousa","year":"2022","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.soncn.2023.151409_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41687-018-0061-6","article-title":"How do patient reported outcome measures (PROMs) support clinician-patient communication and patient care? A realist synthesis","volume":"2","author":"Greenhalgh","year":"2018","journal-title":"J Patient Rep Outcomes"},{"issue":"10","key":"10.1016\/j.soncn.2023.151409_bib0020","first-page":"4357","article-title":"Patient and health care provider perceptions of cancer-related fatigue and pain","volume":"24","author":"Williams","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.soncn.2023.151409_bib0021","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-3-030-01207-6_5","article-title":"Patient-reported outcomes in oncology, beyond randomized controlled trials","volume":"213","author":"Toumi","year":"2019","journal-title":"Recent Results Cancer Res"},{"issue":"6","key":"10.1016\/j.soncn.2023.151409_bib0022","doi-asserted-by":"crossref","DOI":"10.1097\/NCC.0b013e318269040f","article-title":"Comparison between patient-reported and clinician-observed symptoms in oncology","volume":"36","author":"Xiao","year":"2013","journal-title":"Cancer Nurs"},{"issue":"6","key":"10.1016\/j.soncn.2023.151409_bib0023","first-page":"61","article-title":"Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs)","volume":"6","author":"Weldring","year":"2013","journal-title":"Heal Serv Insights"},{"key":"10.1016\/j.soncn.2023.151409_bib0024","article-title":"A rapid review of patient-reported outcomes investigated in the context of advanced renal cell cancer or advanced hepatocellular cancer","volume":"0","author":"Diez de los Rios de la Serna","year":"2022","journal-title":"Eur J Oncol Nurs"},{"issue":"2","key":"10.1016\/j.soncn.2023.151409_bib0025","first-page":"1427","article-title":"The use of patient-reported outcomes in routine cancer care: preliminary insights from a multinational scoping survey of oncology practitioners","volume":"30","author":"Cheung","year":"2022","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.soncn.2023.151409_bib0026","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.euf.2019.02.020","article-title":"Patient-reported outcome measures in metastatic urinary cancers","volume":"6","author":"Bergerot","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.soncn.2023.151409_bib0027","first-page":"305","article-title":"Delphi panels: research design, procedures, advantages, and challenges","volume":"11","author":"Avella","year":"2016","journal-title":"Int J Dr Stud"},{"issue":"1","key":"10.1016\/j.soncn.2023.151409_bib0028","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1016\/j.sapharm.2021.06.027","article-title":"More of an art than a science\u2019? The development, design and mechanics of the Delphi technique","volume":"18","author":"Drumm","year":"2022","journal-title":"Res Soc Adm Pharm"},{"issue":"8","key":"10.1016\/j.soncn.2023.151409_bib0029","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.techfore.2012.04.013","article-title":"Consensus measurement in Delphi studies","volume":"79","author":"von der Gracht","year":"2012","journal-title":"Technol Forecast Soc Change"},{"key":"10.1016\/j.soncn.2023.151409_bib0030","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3389\/fpubh.2020.00457","article-title":"Delphi technique in health sciences: a map","volume":"8","author":"Niederberger","year":"2020","journal-title":"Front Public Heal"},{"issue":"5","key":"10.1016\/j.soncn.2023.151409_bib0031","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/NNR.0000000000000297","article-title":"Methodology update: Delphi studies","volume":"67","author":"McPherson","year":"2018","journal-title":"Nurs Res"},{"key":"10.1016\/j.soncn.2023.151409_bib0032","doi-asserted-by":"crossref","unstructured":"Shariff NJ. Utilizing the Delphi survey approach: a review. Published online 2015. doi:10.4172\/2167-1168.1000246","DOI":"10.4172\/2167-1168.1000246"},{"issue":"1","key":"10.1016\/j.soncn.2023.151409_bib0033","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1108\/14777260310469319","article-title":"Delphi: myths and reality","volume":"17","author":"Mullen","year":"2003","journal-title":"J Health Organ Manag"},{"key":"10.1016\/j.soncn.2023.151409_bib0034","doi-asserted-by":"crossref","first-page":"142","DOI":"10.35680\/2372-0247.1053","article-title":"Patient needs in advanced renal cell carcinoma: what are patients\u2019 priorities and how well are we meeting them?","volume":"2","author":"Harris","year":"2015","journal-title":"Patient Exp J"},{"key":"10.1016\/j.soncn.2023.151409_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2020.05.004","article-title":"The role of religion and spirituality in cancer care: an umbrella review of the literature","volume":"42","author":"Palmer Kelly","year":"2022","journal-title":"Surg Oncol."},{"key":"10.1016\/j.soncn.2023.151409_bib0036","series-title":"European Values Trends and Divides Over Thirty Years","author":"Br\u00e9chon","year":"2017"},{"issue":"6","key":"10.1016\/j.soncn.2023.151409_bib0037","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1188\/17.ONF.665-673","article-title":"Symptom distress in patients with hepatocellular carcinoma toward the end of life","volume":"44","author":"Hansen","year":"2017","journal-title":"Oncol Nurs Forum"},{"issue":"14","key":"10.1016\/j.soncn.2023.151409_bib0038","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2013.53.5948","article-title":"What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials","volume":"32","author":"Kotronoulas","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2023.151409_bib0039","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijnurstu.2018.05.014","article-title":"A scoping review of trials of interventions led or delivered by cancer nurses","volume":"86","author":"Charalambous","year":"2018","journal-title":"Int J Nurs Stud"},{"issue":"9","key":"10.1016\/j.soncn.2023.151409_bib0040","first-page":"5253","article-title":"Patient-reported outcome measures in oncology: a qualitative study of the healthcare professional's perspective","volume":"29","author":"Graupner","year":"2021","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.soncn.2023.151409_bib0041","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.5001\/omj.2020.40","article-title":"Implications of language barriers for healthcare: a systematic review","volume":"35","author":"Al Shamsi","year":"2020","journal-title":"Oman Med J"},{"issue":"2","key":"10.1016\/j.soncn.2023.151409_bib0042","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/jan.14007","article-title":"Strategies for overcoming language barriers in research","volume":"76","author":"Squires","year":"2020","journal-title":"J Adv Nurs"},{"issue":"1","key":"10.1016\/j.soncn.2023.151409_bib0043","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-015-0948-y","article-title":"Recruitment challenges in clinical research including cancer patients and their caregivers. A randomized controlled trial study and lessons learned","volume":"16","author":"Sygna","year":"2015","journal-title":"Trials"},{"issue":"3","key":"10.1016\/j.soncn.2023.151409_bib0044","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/15265161.2016.1276644","article-title":"Using social media as a research recruitment tool: ethical issues and recommendations","volume":"17","author":"Gelinas","year":"2017","journal-title":"Am J Bioeth"},{"issue":"1","key":"10.1016\/j.soncn.2023.151409_bib0045","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-018-0614-7","article-title":"The challenges of recruiting cancer patient\/caregiver dyads: informing randomized controlled trials","volume":"18","author":"Heckel","year":"2018","journal-title":"BMC Med Res Methodol"}],"container-title":["Seminars in Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208123000402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208123000402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:43:08Z","timestamp":1760082188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749208123000402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0749208123000402"],"URL":"https:\/\/doi.org\/10.1016\/j.soncn.2023.151409","relation":{},"ISSN":["0749-2081"],"issn-type":[{"value":"0749-2081","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Delphi Study of Core Patient-Reported Outcomes for Advanced Renal Cell Carcinoma and Advanced Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soncn.2023.151409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151409"}}